Far East Bio-Tec Co., Ltd.
Far East Bio-Tec Co., Ltd. manufactures and sells organic chlorella, spirulina, and dietary supplements. It also offers nutraceuticals/nutritional supplements, immune booster products, antiviral sprays, and pet supplements. The company was founded in 1976 and is based in Taipei, Taiwan.
Market Cap & Net Worth: Far East Bio-Tec Co., Ltd. (6886)
Far East Bio-Tec Co., Ltd. (TWO:6886) has a market capitalization of $48.00 Million (NT$1.59 Billion) as of March 18, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #44353 globally and #1965 in its home market, demonstrating a -0.40% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Far East Bio-Tec Co., Ltd.'s stock price NT$50.00 by its total outstanding shares 31763499 (31.76 Million).
Far East Bio-Tec Co., Ltd. Market Cap History: 2026 to 2026
Far East Bio-Tec Co., Ltd.'s market capitalization history from 2026 to 2026. Data shows growth from $48.00 Million to $48.00 Million (0.00% CAGR).
Far East Bio-Tec Co., Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Far East Bio-Tec Co., Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6886 by Market Capitalization
Companies near Far East Bio-Tec Co., Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to Far East Bio-Tec Co., Ltd. by market ranking:
- Nestle SA (PINK:NSRGF): Ranked #55 globally with a market cap of $258.19 Billion USD.
- Nestlé S.A. (SW:NESN): Ranked #68 globally with a market cap of $226.90 Billion USD ( CHF207.77 Billion CHF).
- Danone S.A (OTCQX:GPDNF): Ranked #437 globally with a market cap of $49.73 Billion USD.
- Danone SA (PA:BN): Ranked #458 globally with a market cap of $47.46 Billion USD ( €46.23 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #55 | Nestle SA | PINK:NSRGF | $258.19 Billion | $100.43 |
| #68 | Nestlé S.A. | SW:NESN | $226.90 Billion | CHF80.84 |
| #437 | Danone S.A | OTCQX:GPDNF | $49.73 Billion | $78.67 |
| #458 | Danone SA | PA:BN | $47.46 Billion | €73.12 |
Far East Bio-Tec Co., Ltd. Historical Marketcap From 2026 to 2026
Between 2026 and today, Far East Bio-Tec Co., Ltd.'s market cap moved from $48.00 Million to $ 48.00 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$48.00 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Far East Bio-Tec Co., Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $48.00 Million USD |
| MoneyControl | $48.00 Million USD |
| MarketWatch | $48.00 Million USD |
| marketcap.company | $48.00 Million USD |
| Reuters | $48.00 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.